|
gentronix provides services and solutions that help companies reduce attrition rates and ensure safer products across a wide range of chemistry driven industries.
Our primary focus is on providing better hazard identification assays for genotoxicity through the use of our patented human cell GADD45a reporter assays GreenScreen® HC and BlueScreen HC.
In addition Gentronix provides out-sourced services for genotoxicity testing and a wide range of other ADME and predictive toxicity endpoints.
Reducing attrition rates due to toxicity concerns is critical to increasing the success of the drug discovery and development process. Identifying toxicity liability early allows precious resources to be directed towards compounds more likely to advance to candidate selection and on to clinical evaluation.
Currently 65 pharmaceutical and fine chemical companies in 15 countries are using GreenScreen HC data as part of their genotoxicity profiling strategy.
|